MarketInOut Stock Screener Log In | Sign Up
 

Anteris Technologies Global Corp

IEX • Healthcare • Medical Devices • Quote as of 08/14/2026
Anteris Technologies Global Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeIEX
Market Capitalization863.48 mln
Float59.83 mln
Earnings Date08/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.98
Likely reliable

Relative Strength

91 / 100
Top performer

Debt / Equity

0.01
Debt-free

ROE

-92.83
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through less invasive procedures. Its flagship product, the DurAVR system, is a catheter-delivered heart valve designed to replicate the natural function of a healthy aortic valve. The company also offers supporting technologies, including a tissue treatment process that improves durability and a specialized delivery system that helps surgeons navigate the heart with greater precision and control.

Key Fundamentals

EPS-1.95
ROE-92.83
RPS0.04
ROIC-1,021
ROA-79.77
EBITDA, mln-100
EV / EBITDA-6.20
EV / EBIT-6.09
Revenue, mln2.24
EV / Revenue278

Financial Strength

Altman Z-Score22.56
Piotroski F-Score 5 / 9
Beneish M-Score-2.98
Short Ratio6.05
Short % of Float10.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.5% 88 / 100   
1 Month 12.71% 85 / 100   
2 Months 44.39% 95 / 100   
6 Months 65.49% 94 / 100   
1 Year 132% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us